Current Report Filing (8-k)
November 18 2015 - 05:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 10, 2015
DAVITA HEALTHCARE PARTNERS INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
1-14106 |
|
No. 51-0354549 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
2000 16th Street
Denver, CO 80202
(Address
of principal executive offices including Zip Code)
(303) 405-2100
(Registrants telephone number, including area code)
Not applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
On November 10, 2015, RMS Lifeline, Inc., a wholly owned subsidiary
of DaVita HealthCare Partners Inc. (the Company) that operates under the name Lifeline Vascular AccessSM (Lifeline), received a Civil Investigative Demand (the
CID) from the U.S. Department of Justice (the DOJ). The CID relates to two vascular access centers in Florida that are part of Lifelines vascular access business. The CID covers the period from January 1, 2008
through the present.
Based on the language of the CID, the DOJ is conducting a False Claims Act investigation and appears to be reviewing
the medical necessity of angiograms performed at the two centers. The CID seeks, among other documents, medical records for 10 patients. Lifeline does not perform dialysis services but instead provides vascular access management services for
dialysis patients.
The Company maintains policies and procedures to promote compliance with the False Claims Act and other applicable
laws and regulations, and intends to cooperate with the government. The Company cannot predict, however, when this investigation will be resolved, its eventual outcome or scope, or its potential impact on the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
DAVITA HEALTHCARE PARTNERS INC. |
|
|
|
|
Date: November 18, 2015 |
|
|
|
By: |
|
/s/ James K. Hilger |
|
|
|
|
|
|
James K. Hilger |
|
|
|
|
|
|
Interim Chief Financial Officer and
Chief Accounting Officer |
DaVita (NYSE:DVA)
Historical Stock Chart
From Feb 2024 to Mar 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Mar 2023 to Mar 2024